Association of Statin, Metformin, and Aspirin Use With Hepatocellular Carcinoma in the Research Program.
作者信息
Almazan Erik, Chung Raymond T
机构信息
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
出版信息
Gastro Hep Adv. 2024 Aug 24;4(1):100535. doi: 10.1016/j.gastha.2024.08.014. eCollection 2025.
Abstract
摘要
相似文献
1
Association of Statin, Metformin, and Aspirin Use With Hepatocellular Carcinoma in the Research Program.研究项目中他汀类药物、二甲双胍和阿司匹林的使用与肝细胞癌的关联
Gastro Hep Adv. 2024 Aug 24;4(1):100535. doi: 10.1016/j.gastha.2024.08.014. eCollection 2025.
2
Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis.围手术期使用他汀类药物、二甲双胍和阿司匹林与肝细胞癌患者根治性肝切除术后复发的相关性：倾向评分匹配分析。
Cancer Med. 2023 Oct;12(19):19548-19559. doi: 10.1002/cam4.6569. Epub 2023 Sep 22.
3
Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.荟萃分析：他汀类药物、阿司匹林和二甲双胍预防肝细胞癌。
Aliment Pharmacol Ther. 2023 Mar;57(6):600-609. doi: 10.1111/apt.17371. Epub 2023 Jan 10.
4
Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study.他汀类药物、阿司匹林和二甲双胍的使用与肝移植后肝细胞癌相关结局的风险：一项回顾性研究。
World J Transplant. 2024 Sep 18;14(3):94914. doi: 10.5500/wjt.v14.i3.94914.
5
Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis.阿司匹林、二甲双胍和他汀类药物的使用与胃癌风险：韩国一项全国性基于人群的队列研究及系统评价和荟萃分析。
Cancer Med. 2022 Feb;11(4):1217-1231. doi: 10.1002/cam4.4514. Epub 2021 Dec 30.
6
Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.二甲双胍治疗 2 型糖尿病患者与肝细胞癌风险的关系。
Liver Int. 2018 Nov;38(11):2018-2027. doi: 10.1111/liv.13872. Epub 2018 Jun 29.
7
Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study.阿司匹林、二甲双胍和他汀类药物的使用与胃癌发病率和死亡率的关联：一项全国性队列研究。
Cancer Prev Res (Phila). 2021 Jan;14(1):95-104. doi: 10.1158/1940-6207.CAPR-20-0123. Epub 2020 Sep 16.
8
Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.二甲双胍预防糖尿病患者肝细胞癌：系统评价。
Ann Hepatol. 2020 May-Jun;19(3):232-237. doi: 10.1016/j.aohep.2019.10.005. Epub 2019 Nov 28.
9
Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.他汀类药物、阿司匹林或二甲双胍的使用对胆管癌患者无复发生存率和总生存率的影响。
Hepatogastroenterology. 2015 May;62(139):564-9.
10
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?他汀类药物和阿司匹林用于肝癌的化学预防：现在使用还是等待进一步研究？
Clin Mol Hepatol. 2022 Jul;28(3):380-395. doi: 10.3350/cmh.2021.0366. Epub 2022 Jan 13.
本文引用的文献
1
Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades.美国按性别、年龄和种族划分的肝细胞癌发病率和死亡率：二十年全国性分析
J Clin Transl Hepatol. 2024 Feb 28;12(2):172-181. doi: 10.14218/JCTH.2023.00356. Epub 2024 Jan 2.
2
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
3
Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.荟萃分析：他汀类药物、阿司匹林和二甲双胍预防肝细胞癌。
Aliment Pharmacol Ther. 2023 Mar;57(6):600-609. doi: 10.1111/apt.17371. Epub 2023 Jan 10.
4
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature.阿托伐他汀可正向调节临床肝细胞癌风险基因特征。
Hepatol Commun. 2022 Sep;6(9):2581-2593. doi: 10.1002/hep4.1991. Epub 2022 Jun 16.
5
Effect of Liver Disease on Hepatic Transporter Expression and Function.肝脏疾病对肝转运体表达及功能的影响。
J Pharm Sci. 2017 Sep;106(9):2282-2294. doi: 10.1016/j.xphs.2017.04.053. Epub 2017 Apr 30.
6
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.在丙型肝炎病毒患者中，阿托伐他汀和氟伐他汀与肝硬化和肝细胞癌的剂量依赖性降低相关：ERCHIVES研究结果。
Hepatology. 2016 Jul;64(1):47-57. doi: 10.1002/hep.28506. Epub 2016 Mar 25.
7
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C.他汀类药物的使用与慢性丙型肝炎纤维化进展风险降低相关。
J Hepatol. 2015 Jan;62(1):18-23. doi: 10.1016/j.jhep.2014.08.013. Epub 2014 Aug 15.
8
Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?美国肝细胞癌的流行病学：我们目前的状况如何？我们将何去何从？
Hepatology. 2014 Nov;60(5):1767-75. doi: 10.1002/hep.27222. Epub 2014 Aug 25.
9
Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.他汀类药物与肝细胞癌风险降低相关：系统评价和荟萃分析。
Gastroenterology. 2013 Feb;144(2):323-332. doi: 10.1053/j.gastro.2012.10.005. Epub 2012 Oct 12.
10
Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites.普伐他汀和辛伐他汀对不同部位肿瘤细胞生长的影响差异。
PLoS One. 2011;6(12):e28813. doi: 10.1371/journal.pone.0028813. Epub 2011 Dec 22.
Zotero 插件